The Norwich Pharma Services manufacturing facility in Norwich, New York is as varied in its capabilities as it is its equipment investment strategy. This dedication to growth through equipment and technology investment has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.
Custom Processing Services has a strong track record of contract manufacturing in the...
New development technologies, expanded contract manufacturing and service capabilities, as well...
Olympus Biotech today announced the initiation of an aggressive transaction process to find a...
The Jan/Feb 2014 issue of Pharmaceutical Processing is our INTERPHEX 2014 Preview issue and features numerous exhibitor highlights and a guide to the educational conference program. In addition, we profile Xcelience, a clinical trial material contract manufacturer based in Tampa, FL.
Pharmaceutical Processing's Editor In Chief Mike Auerbach discusses current and future outsourcing trends with a select group of companies.
Mayne Pharma Group Limited has named Stefan Cross as president of Mayne Pharma USA. Cross is responsible for leading all of Mayne Pharma’s existing business operations in the United States, and for spearheading new business development initiatives.
Metrics Inc. is a full-service global CDMO. Our expertise includes FTIM formulations; Phases I-III CTM manufacturing; and analytical support services leading to commercial manufacturing. Capabilities include potent compounds, Schedule II-V controlled substances, and products with poor bioequivalence, for which we offer advanced delivery methods.
LSNE is a CMO with a proven regulatory history, specializing in process development, aseptic fill/finish and lyophilization. No matter what stage of development you are in, our development team can partner with you to optimize your manufacturing process.
OSO BioPharmaceuticals Manufacturing LLC is a CMO that delivers injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products to the pharmaceutical industry. Company offers significant knowledge and experience in late-phase clinical products and taking them to commercialization.
Unique Pharmaceuticals, Ltd. has voluntarily registered with the U.S. Food and Drug Administration (FDA) as a Human Drug Compounding Outsourcing Facility following guidance from the recently enacted Drug Quality and Security Act.
SP Scientific and AAIPharma Services Corp. have entered into a purchase agreement where SP will supply AAIPharma with a LyoStar 3 pilot-scale lyophilizer paired with a complementing Hull production-scale lyophilizer, both equipped with Praxair’s ControLyo™ Nucleation On-Demand Technology.
CCBR-SYNARC and BioClinica, Inc. have signed an agreement to merge their companies to create a global provider of specialized outsourced clinical services. The combined company will offer a portfolio of services uniquely tailored to conducting and managing global clinical trials on behalf of the world's premier pharmaceutical and biotechnology companies.
A focus on core competencies allows Xcelience to deliver clinical trial materials with speed, efficiency and quality.
AAIPharma Services a provider of pharmaceutical analytical testing, product development and manufacturing services, announced today that it has completed a multi-million dollar expansion of its cGMP parenteral manufacturing facility in Charleston, S.C.
Outsourcing of biopharmaceutical manufacturing has been growing for several years, to the point where contract manufacturing has become a common strategic decision for developers, extending beyond simple non-core activities and into more high-value, technical ones that leverage offerings from contract manufacturing organizations (CMOs) that some developers do not have in-house.
Ajinomoto Althea Inc., a CMO providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today the appointment of J. David Enloe Jr. as President and CEO. Mr. Enloe will be responsible for developing strategies to support the company's continued growth.
Quintiles has announced the appointment of W. Scott Evangelista to serve as president, Integrated Commercial Services and Solutions. In this role, Evangelista is responsible for leading Quintiles’ global Commercial organization and the ongoing development and delivery of its related service offerings.
Charles River Laboratories today announced organizational changes which are designed to continue to improve the company’s operating efficiency across its global portfolio and enhance its ability to meet the needs of its clients. These changes represent the next step in Charles River’s continuing effort to position the Company as the partner of choice for early-stage drug development and to drive future growth.
Our annual reader survey looks at issues facing innovator companies and the CMO/CSOs that support them.
The company reported that Novartis wants to use one of its injectable drug delivery systems with an experimental drug in early-stage testing. Unilife said it will supply Novartis with a customized drug delivery device that will allow the Novartis drug to be delivered to a targeted organ.
AAIPharma Services, Corp. and Cambridge Major Laboratories, Inc. have announced the appointment of Eric Evans as the Chief Financial Officer (CFO) of the merged company (“AAI-CML”). Evans brings more than 25 years of experience in financial leadership roles; most recently as chief financial officer of AAIPharma Services, Corp.
Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company's senior management leadership team. Dr. Goldman will focus his efforts on the growth of Aptuit as a leading provider of outsourced services in the early development space by establishing new partnerships with clients and pursuing strategic acquisitions.
Xcelience announced today the hiring of Joseph Iacobucci as Vice President of Clinical Supplies and Services. Mr. Iacobucci brings nearly 30 years of experience in clinical packaging and supply services, including 23 years as a Vice President for Clinical Systems, Inc.
Dutch chemicals maker Royal DSM NV has struck a deal to buy Canada's Patheon Inc. for $195 million (145 million euros), combine it with its own drug manufacturing operations, and spin them off into a new larger company.
Eurofins Lancaster Labs and Celsis International to Provide Rapid Micro Validation and Screening ServicesNovember 18, 2013 8:02 am | News | Comments
Eurofins Lancaster Laboratories and Celsis International Ltd. announced today that they have entered into a collaboration through which Eurofins Lancaster Laboratories will provide contract rapid microbiology validation and screening services for the Celsis rapid detection technology platform.
Bend Research Inc., part of Capsugel’s Dosage Form Solutions (DFS) business unit, announced today an investment of more than $20 million to expand commercial manufacturing for spray-dried dispersions at its facilities in Bend, Ore. The investment will encompass a facility expansion dedicated to commercial manufacturing with two new high-capacity PSD spray dryer process trains.
Hospira has unveiled a new quality and analytical testing laboratory at its Rocky Mount, N.C., plant in a ribbon-cutting ceremony attended by North Carolina Governor Pat McCrory and other local and state government leaders.
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, today announced that it has changed its name to Norwich Pharma Services.
- Page 1